Citation: Dg. Carlson et Wh. Widen, The earmarking defense to voidable preference liability: A reconceptualization, AM BANKRUPT, 73(3), 1999, pp. 591-652
Authors:
Snyder, DW
Bach, NJ
Dillard, RD
Draheim, SE
Carlson, DG
Fox, N
Roehm, NW
Armstrong, CT
Chang, CH
Hartley, LW
Johnson, LM
Roman, CR
Smith, AC
Song, M
Fleisch, JH
Citation: Dw. Snyder et al., Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetate, a potent and selective secretory phospholipase A(2) inhibitor: A new class of anti-inflammatory drugs, SPI, J PHARM EXP, 288(3), 1999, pp. 1117-1124